位置:首页 > 蛋白库 > CAH_AZOC5
CAH_AZOC5
ID   CAH_AZOC5               Reviewed;         356 AA.
AC   A8IKD2;
DT   10-MAY-2017, integrated into UniProtKB/Swiss-Prot.
DT   04-DEC-2007, sequence version 1.
DT   03-AUG-2022, entry version 67.
DE   RecName: Full=Cyanuric acid amidohydrolase {ECO:0000255|HAMAP-Rule:MF_01989};
DE            Short=CAH {ECO:0000255|HAMAP-Rule:MF_01989};
DE            EC=3.5.2.15 {ECO:0000255|HAMAP-Rule:MF_01989, ECO:0000269|PubMed:22730121};
GN   OrderedLocusNames=AZC_3892;
OS   Azorhizobium caulinodans (strain ATCC 43989 / DSM 5975 / JCM 20966 / LMG
OS   6465 / NBRC 14845 / NCIMB 13405 / ORS 571).
OC   Bacteria; Proteobacteria; Alphaproteobacteria; Hyphomicrobiales;
OC   Xanthobacteraceae; Azorhizobium.
OX   NCBI_TaxID=438753;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 43989 / DSM 5975 / JCM 20966 / LMG 6465 / NBRC 14845 / NCIMB
RC   13405 / ORS 571;
RA   Lee K.B., Backer P.D., Aono T., Liu C.T., Suzuki S., Suzuki T., Kaneko T.,
RA   Yamada M., Tabata S., Kupfer D.M., Najar F.Z., Wiley G.B., Roe B.,
RA   Binnewies T., Ussery D., Vereecke D., Gevers D., Holsters M., Oyaizu H.;
RT   "Complete genome sequence of the nitrogen-fixing bacterium Azorhizobium
RT   caulinodans ORS571.";
RL   Submitted (APR-2007) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=22730121; DOI=10.1128/jb.00791-12;
RA   Seffernick J.L., Erickson J.S., Cameron S.M., Cho S., Dodge A.G.,
RA   Richman J.E., Sadowsky M.J., Wackett L.P.;
RT   "Defining sequence space and reaction products within the cyanuric acid
RT   hydrolase (AtzD)/barbiturase protein family.";
RL   J. Bacteriol. 194:4579-4588(2012).
RN   [3]
RP   SUBUNIT.
RX   PubMed=23908033; DOI=10.1107/s1744309113017077;
RA   Cho S., Shi K., Wackett L.P., Aihara H.;
RT   "Crystallization and preliminary X-ray diffraction studies of cyanuric acid
RT   hydrolase from Azorhizobium caulinodans.";
RL   Acta Crystallogr. F 69:880-883(2013).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) IN COMPLEX WITH MAGNESIUM AND
RP   INHIBITOR, ACTIVE SITE, AND MUTAGENESIS OF LYS-40; SER-79; LYS-156;
RP   SER-226; LYS-285 AND SER-333.
RX   PubMed=24915109; DOI=10.1371/journal.pone.0099349;
RA   Cho S., Shi K., Seffernick J.L., Dodge A.G., Wackett L.P., Aihara H.;
RT   "Cyanuric acid hydrolase from Azorhizobium caulinodans ORS 571: crystal
RT   structure and insights into a new class of Ser-Lys dyad proteins.";
RL   PLoS ONE 9:E99349-E99349(2014).
CC   -!- FUNCTION: Responsible for the hydrolysis of cyanuric acid, an
CC       intermediate formed during catabolism of s-triazine based compounds in
CC       herbicides such as atrazine and polymers such as melamine. Catalyzes
CC       the hydrolytic opening of the s-triazine ring of cyanuric acid (2,4,6-
CC       trihydroxy-s-triazine) to yield carbon dioxide and carboxybiuret, which
CC       spontaneously decarboxylates to biuret. {ECO:0000255|HAMAP-
CC       Rule:MF_01989, ECO:0000269|PubMed:22730121}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cyanurate + H2O = 1-carboxybiuret + H(+);
CC         Xref=Rhea:RHEA:70363, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:38028, ChEBI:CHEBI:142864; EC=3.5.2.15;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_01989,
CC         ECO:0000269|PubMed:22730121};
CC   -!- ACTIVITY REGULATION: Inhibited by barbituric acid.
CC       {ECO:0000250|UniProtKB:P58329, ECO:0000255|HAMAP-Rule:MF_01989}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=370 uM for cyanuric acid {ECO:0000269|PubMed:22730121};
CC         Note=kcat is 50 sec(-1) with cyanuric acid as substrate.
CC         {ECO:0000269|PubMed:22730121};
CC   -!- PATHWAY: Xenobiotic degradation; atrazine degradation; biuret from
CC       cyanurate: step 1/1. {ECO:0000255|HAMAP-Rule:MF_01989}.
CC   -!- SUBUNIT: Homotetramer. {ECO:0000255|HAMAP-Rule:MF_01989,
CC       ECO:0000269|PubMed:23908033}.
CC   -!- DOMAIN: The monomer structure is formed from three repeating units
CC       (RUs) that share the same structure as one another. The monomer, the
CC       active site and substrate all possess threefold rotational symmetry, to
CC       the extent that the active site possesses three potential Ser-Lys
CC       catalytic dyads. It is possible that any or all of the three active-
CC       site serines may act as nucleophile (albeit only one can do so per
CC       catalytic cycle). Mutant, bioinformatic and structural data propose one
CC       specific dyad being involved in catalysis. {ECO:0000255|HAMAP-
CC       Rule:MF_01989, ECO:0000305|PubMed:24915109}.
CC   -!- SIMILARITY: Belongs to the cyclic amide hydrolase (CyAH) family.
CC       {ECO:0000255|HAMAP-Rule:MF_01989, ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP009384; BAF89890.1; -; Genomic_DNA.
DR   RefSeq; WP_012172412.1; NC_009937.1.
DR   PDB; 4NQ3; X-ray; 2.70 A; A/B=1-356.
DR   PDBsum; 4NQ3; -.
DR   AlphaFoldDB; A8IKD2; -.
DR   SMR; A8IKD2; -.
DR   STRING; 438753.AZC_3892; -.
DR   EnsemblBacteria; BAF89890; BAF89890; AZC_3892.
DR   KEGG; azc:AZC_3892; -.
DR   eggNOG; ENOG502Z8BS; Bacteria.
DR   HOGENOM; CLU_808206_0_0_5; -.
DR   OMA; GRYRIGH; -.
DR   OrthoDB; 984718at2; -.
DR   UniPathway; UPA00008; UER00502.
DR   Proteomes; UP000000270; Chromosome.
DR   GO; GO:0018753; F:cyanuric acid amidohydrolase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0019381; P:atrazine catabolic process; IEA:UniProtKB-UniRule.
DR   Gene3D; 3.30.1330.160; -; 1.
DR   Gene3D; 3.30.1330.170; -; 1.
DR   Gene3D; 3.30.1330.180; -; 1.
DR   HAMAP; MF_01989; Cyc_amidohydrol; 1.
DR   InterPro; IPR014086; AtzD/Barbiturase.
DR   InterPro; IPR043008; AtzD/Barbiturase_RUA.
DR   InterPro; IPR043006; AtzD/Barbiturase_RUB.
DR   InterPro; IPR043007; AtzD/Barbiturase_RUC.
DR   Pfam; PF09663; Amido_AtzD_TrzD; 1.
DR   TIGRFAMs; TIGR02714; amido_AtzD_TrzD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Hydrolase; Magnesium; Metal-binding; Reference proteome.
FT   CHAIN           1..356
FT                   /note="Cyanuric acid amidohydrolase"
FT                   /id="PRO_0000439909"
FT   REGION          1..99
FT                   /note="RU A"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989"
FT   REGION          106..243
FT                   /note="RU B"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989"
FT   REGION          249..356
FT                   /note="RU C"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989"
FT   ACT_SITE        156
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   ACT_SITE        226
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         52
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         79..80
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         188
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         226..227
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         287
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         314
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         333..334
FT                   /ligand="substrate"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         336
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         339
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         340
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         341
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   BINDING         344
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989,
FT                   ECO:0000269|PubMed:24915109"
FT   SITE            310
FT                   /note="Important for substrate specificity"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_01989"
FT   MUTAGEN         40
FT                   /note="K->A: Reduces catalytic activity 1e4-fold."
FT                   /evidence="ECO:0000269|PubMed:24915109"
FT   MUTAGEN         79
FT                   /note="S->A: Reduces catalytic activity 1e8-fold."
FT                   /evidence="ECO:0000269|PubMed:24915109"
FT   MUTAGEN         156
FT                   /note="K->A: Reduces catalytic activity 1e4-fold."
FT                   /evidence="ECO:0000269|PubMed:24915109"
FT   MUTAGEN         226
FT                   /note="S->A: Reduces catalytic activity 1e9-fold."
FT                   /evidence="ECO:0000269|PubMed:24915109"
FT   MUTAGEN         285
FT                   /note="K->A: Reduces catalytic activity 1e4-fold."
FT                   /evidence="ECO:0000269|PubMed:24915109"
FT   MUTAGEN         333
FT                   /note="S->A: Reduces catalytic activity 1e8-fold."
FT                   /evidence="ECO:0000269|PubMed:24915109"
FT   STRAND          2..10
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           18..25
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           31..33
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          34..43
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           51..67
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           68..73
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          74..80
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          89..97
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          106..113
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   TURN            119..123
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           125..141
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          150..157
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           162..170
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           180..199
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           204..206
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   TURN            209..214
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          220..227
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          235..242
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          246..258
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           263..271
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          281..286
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          292..294
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          305..307
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   HELIX           309..325
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          331..334
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          339..341
FT                   /evidence="ECO:0007829|PDB:4NQ3"
FT   STRAND          345..352
FT                   /evidence="ECO:0007829|PDB:4NQ3"
SQ   SEQUENCE   356 AA;  36040 MW;  231B48FE327A4E3C CRC64;
     MPIAKVHRIA TASPDDVSGL AAAIATGAIA PAGILAIFGK TEGNGCVNDF SRGFAVQSLQ
     MLLRGHMGAA ADEVCLVMSG GTEGGMSPHF LVFERAEGNA PEAAPALAIG RAHTPDLPFE
     ALGRMGQVRM VAQAVRRAMA AAGITDPEDV HFVQVKCPLL TAMRVKEAEA RGATTATSDT
     LKSMGLSRGA SALGIALALG EVAEDALSDA VICADYGLWS ARASCSSGIE LLGHEIVVLG
     MSEGWSGPLA IAHGVMADAI DVTPVKAALS ALGAEAGEAT IVLAKAEPSR SGRIRGKRHT
     MLDDSDISPT RHARAFVAGA LAGVVGHTEI YVSGGGEHQG PDGGGPVAVI AARTMG
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024